“…Four previous studies have identified a number of patient characteristics and biomarkers associated with the prediction of gestational diabetes [11,14,17,18]. These have been undertaken in populations of mixed risk, including non-white ethnicity [11,17,18], family history of diabetes [11,14,17,18], previous history of gestational diabetes [11,17,18], high pre-pregnancy BMI [11,14,18], older maternal age [11,17,18] and differing parity [14]. Savvidou et al [14] measured nine biomarkers in the first trimester and found that high tissue plasminogen activator and low HDL increased the area under the receiver-operating curve from 0.824 with clinical risk factors alone to 0.861 in a group of all comers, regardless of baseline BMI.…”